News
EXOZ
5.70
+9.62%
0.50
Weekly Report: what happened at EXOZ last week (0803-0807)?
Weekly Report · 1d ago
Weekly Report: what happened at EXOZ last week (0727-0731)?
Weekly Report · 08/03 09:22
Weekly Report: what happened at EXOZ last week (0720-0724)?
Weekly Report · 07/27 09:23
eXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing
Benzinga · 07/23 20:25
eXoZymes Selected for DoE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free Biomanufacturing
Barchart · 07/23 15:15
Weekly Report: what happened at EXOZ last week (0713-0717)?
Weekly Report · 07/20 09:22
eXoZymes Inc trading resumes
TipRanks · 07/15 13:46
eXoZymes Inc trading halted, volatility trading pause
TipRanks · 07/15 13:41
Weekly Report: what happened at EXOZ last week (0706-0710)?
Weekly Report · 07/13 09:22
Weekly Report: what happened at EXOZ last week (0629-0703)?
Weekly Report · 07/06 09:24
eXoZymes Completes New Securities Offering to Fund Pipeline
TipRanks · 07/01 21:03
Q2 Virtual Investor Summit Presentations Now Available On Demand
Barchart · 06/30 12:20
Weekly Report: what happened at EXOZ last week (0622-0626)?
Weekly Report · 06/29 09:22
eXoZymes Secures NIH Grant to Advance Cannabinoid Pipeline
TipRanks · 06/26 10:30
eXoZymes awarded $2M NIH Grant to advance cannabinoid analogs for drug discovery
Seeking Alpha · 06/24 20:21
eXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery
Benzinga · 06/24 20:15
Weekly Report: what happened at EXOZ last week (0615-0619)?
Weekly Report · 06/22 09:25
eXoZymes Completes Nasdaq Equity Offering to Fund Pipeline
TipRanks · 06/17 22:45
eXoZymes Inc. Announces Closing of $6 Million Public Offering
Barchart · 06/17 15:10
Weekly Report: what happened at EXOZ last week (0608-0612)?
Weekly Report · 06/15 09:25
More
Webull provides a variety of real-time EXOZ stock news. You can receive the latest news about eXoZymes Inc through multiple platforms. This information may help you make smarter investment decisions.
About EXOZ
eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.